Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 901 to 907 of 907 entries
Sorted by: Best Match Show Resources per page
Hypoxia-sensitive drug delivery to tumors.

Journal of controlled release : official journal of the Controlled Release Society

Filipczak N, Joshi U, Attia SA, Berger Fridman I, Cohen S, Konry T, Torchilin V.
PMID: 34838607
J Control Release. 2021 Nov 24;341:431-442. doi: 10.1016/j.jconrel.2021.11.034. Epub 2021 Nov 24.

Achievement of a high dose of drug in the tumor while minimizing its systemic side effects is one of the important features of an improved drug delivery system. Thus, developing responsive carriers for site-specific delivery of chemotherapeutic agents has...

COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic.

Gynecologic oncology

Lara OD, Smith M, Wang Y, O'Cearbhaill RE, Blank SV, Kolev V, Carr C, Knisely A, McEachron J, Gabor L, Chapman-Davis E, Cohen S, Fehniger J, Lee YC, Isani S, Liu M, Wright JD, Pothuri B.
PMID: 34922769
Gynecol Oncol. 2021 Dec 07; doi: 10.1016/j.ygyno.2021.12.004. Epub 2021 Dec 07.

BACKGROUND: Despite significant increase in COVID-19 publications, characterization of COVID-19 infection in patients with gynecologic cancer remains limited. Here we present an update of COVID-19 outcomes among people with gynecologic cancer in New York City (NYC) during the initial...

Reply to Kissane and Eggington.

American journal of physiology. Cell physiology

Tropp N, Gilda JE, Cohen S.
PMID: 34874767
Am J Physiol Cell Physiol. 2021 Dec 01;321(6):C1084-C1085. doi: 10.1152/ajpcell.00393.2021.

No abstract available.

Complete vertebrate mitogenomes reveal widespread repeats and gene duplications.

Genome biology

Formenti G, Rhie A, Balacco J, Haase B, Mountcastle J, Fedrigo O, Brown S, Capodiferro MR, Al-Ajli FO, Ambrosini R, Houde P, Koren S, Oliver K, Smith M, Skelton J, Betteridge E, Dolucan J, Corton C, Bista I, Torrance J, Tracey A, Wood J, Uliano-Silva M, Howe K, McCarthy S, Winkler S, Kwak W, Korlach J, Fungtammasan A, Fordham D, Costa V, Mayes S, Chiara M, Horner DS, Myers E, Durbin R, Achilli A, Braun EL, Phillippy AM, Jarvis ED.
PMID: 33910595
Genome Biol. 2021 Apr 29;22(1):120. doi: 10.1186/s13059-021-02336-9.

BACKGROUND: Modern sequencing technologies should make the assembly of the relatively small mitochondrial genomes an easy undertaking. However, few tools exist that address mitochondrial assembly directly.RESULTS: As part of the Vertebrate Genomes Project (VGP) we develop mitoVGP, a fully...

Who is Right? A Word-Identification-in-Noise Test for Young Children Using Minimal Pair Distracters.

Journal of speech, language, and hearing research : JSLHR

Evans S, Rosen S.
PMID: 34910569
J Speech Lang Hear Res. 2022 Jan 12;65(1):159-168. doi: 10.1044/2021_JSLHR-20-00658. Epub 2021 Dec 15.

PURPOSE: Many children have difficulties understanding speech. At present, there are few assessments that test for subtle impairments in speech perception with normative data from U.K. children. We present a new test that evaluates children's ability to identify target...

Speech recognition with a hearing-aid processing scheme combining beamforming with mask-informed speech enhancement.

Trends in hearing

Green T, Hilkhuysen G, Huckvale M, Rosen S, Brookes M, Moore A, Naylor P, Lightburn L, Xue W.
PMID: 34985356
Trends Hear. 2022 Jan-Dec;26:23312165211068629. doi: 10.1177/23312165211068629.

A signal processing approach combining beamforming with mask-informed speech enhancement was assessed by measuring sentence recognition in listeners with mild-to-moderate hearing impairment in adverse listening conditions that simulated the output of behind-the-ear hearing aids in a noisy classroom. Two...

Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach.

Bolen S, Tilburt J, Baffi C, Gary TL, Powe N, Howerton M, Ford J, Lai G, Wilson R, Bass E.
UIID-AD: 2950
2006;106:1197-204. doi: 10.1002/cncr.21745.

Although medically underserved groups bear a heavy burden of cancer disease and governmental agencies have required inclusion of minorities and women in cancer clinical trials since 1993, many of these groups are underrepresented in cancer prevention or treatment clinical...

Showing 901 to 907 of 907 entries